Survival of antigen-experienced T cells is essential for the generation of adaptive immune responses. Here, we show that the genetic and antibody-mediated inactivation of CD152 (cytotoxic T lymphocyte antigen 4) in T helper (Th) effector cells reduced the frequency of nonapoptotic cells in a completely Fas/Fas ligand (FasL)–dependent manner. CD152 cross-linking together with stimulation of CD3 and CD28 on activated Th2 cells prevented activation-induced cell death (AICD) as a result of reduced Fas and FasL expression. Apoptosis protection conferred by CD152 correlated with the up-regulation of Bcl-2 and was mediated by phosphatidylinositol 3 kinase, which prevented FasL expression through the inhibitory phosphorylation of Forkhead transcription factor FKHRL1. We show that signals induced by CD152 act directly on activated T lymphocytes and, due to its differential surface expression on activated Th1 and Th2 cells, induce resistance to AICD mainly in Th2 cells.
Skip Nav Destination
Article navigation
15 March 2004
Article|
March 08 2004
CD152 (CTLA-4) Determines the Unequal Resistance of Th1 and Th2 Cells against Activation-induced Cell Death by a Mechanism Requiring PI3 Kinase Function
Pushpa Pandiyan,
Pushpa Pandiyan
1Deutsches Rheuma-Forschungszentrum Berlin
Search for other works by this author on:
Dagmar Gärtner,
Dagmar Gärtner
1Deutsches Rheuma-Forschungszentrum Berlin
Search for other works by this author on:
Osman Soezeri,
Osman Soezeri
1Deutsches Rheuma-Forschungszentrum Berlin
Search for other works by this author on:
Andreas Radbruch,
Andreas Radbruch
1Deutsches Rheuma-Forschungszentrum Berlin
Search for other works by this author on:
Klaus Schulze-Osthoff,
Klaus Schulze-Osthoff
2Institut für Molekulare Medizin, Universität Düsseldorf,
Search for other works by this author on:
Monika C. Brunner-Weinzierl
Monika C. Brunner-Weinzierl
1Deutsches Rheuma-Forschungszentrum Berlin
3Medizinische Kliniken der Humboldt-Universität zu Berlin, Charité, 10117 Berlin, Germany
Search for other works by this author on:
Pushpa Pandiyan
1Deutsches Rheuma-Forschungszentrum Berlin
Dagmar Gärtner
1Deutsches Rheuma-Forschungszentrum Berlin
Osman Soezeri
1Deutsches Rheuma-Forschungszentrum Berlin
Andreas Radbruch
1Deutsches Rheuma-Forschungszentrum Berlin
Klaus Schulze-Osthoff
2Institut für Molekulare Medizin, Universität Düsseldorf,
Monika C. Brunner-Weinzierl
1Deutsches Rheuma-Forschungszentrum Berlin
3Medizinische Kliniken der Humboldt-Universität zu Berlin, Charité, 10117 Berlin, Germany
Address correspondence to Monika C. Brunner-Weinzierl, Deutsches Rheuma-Forschungszentrum, Schumannstrasse 21/22, 10117 Berlin, Germany. Phone: 49-30-28460-721; Fax: 49-30-28460-603; email: [email protected]
Abbreviations used in this paper: AICD, activation-induced cell death; CFSE, 5,6-carboxyfluorescein diacetate succinimidyl ester; dB-cAMP, dibutyryl cAMP; FasL, Fas ligand; tg, transgenic; PI, propidium iodide; PI3 K, phosphatidylinositol 3 kinase; TUNEL, TdT-mediated dUTP nick-end labeling.
Received:
June 27 2003
Accepted:
January 23 2004
Online ISSN: 1540-9538
Print ISSN: 0022-1007
The Rockefeller University Press
2004
J Exp Med (2004) 199 (6): 831–842.
Article history
Received:
June 27 2003
Accepted:
January 23 2004
Citation
Pushpa Pandiyan, Dagmar Gärtner, Osman Soezeri, Andreas Radbruch, Klaus Schulze-Osthoff, Monika C. Brunner-Weinzierl; CD152 (CTLA-4) Determines the Unequal Resistance of Th1 and Th2 Cells against Activation-induced Cell Death by a Mechanism Requiring PI3 Kinase Function . J Exp Med 15 March 2004; 199 (6): 831–842. doi: https://doi.org/10.1084/jem.20031058
Download citation file:
Sign in
Don't already have an account? Register
Client Account
You could not be signed in. Please check your email address / username and password and try again.
Could not validate captcha. Please try again.
Sign in via your Institution
Sign in via your InstitutionSuggested Content
Email alerts
Advertisement